Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97

Current Biology

Volumn 24, Issue 14, 2014, Pages 1573-1583

  Sha, Zhe ^a   Goldberg, Alfred L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATP DEPENDENT 26S PROTEASE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; BORONIC ACID DERIVATIVE; BORTEZOMIB; EPOXOMICIN; LEUPEPTIN; NRF1 PROTEIN, HUMAN; NUCLEAR PROTEIN; NUCLEAR RESPIRATORY FACTOR 1; OLIGOPEPTIDE; PROTEASOME; PROTEASOME ACTIVATOR 200 KDA, HUMAN; PROTEASOME INHIBITOR; PYRAZINE DERIVATIVE; SMALL INTERFERING RNA; UBIQUITIN THIOLESTERASE; USP14 PROTEIN, HUMAN;

BIOSYNTHESIS; CELL LINE; ENDOPLASMIC RETICULUM; HEK293 CELL LINE; HUMAN; METABOLISM; PROTEIN DEGRADATION; RNA INTERFERENCE; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE;

BORONIC ACIDS; BORTEZOMIB; CELL LINE; ENDOPLASMIC RETICULUM; HEK293 CELLS; HUMANS; LEUPEPTINS; NUCLEAR PROTEINS; NUCLEAR RESPIRATORY FACTOR 1; OLIGOPEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; PROTEOLYSIS; PYRAZINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITIN THIOLESTERASE; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE;

EID: 84904990897     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2014.06.004     Document Type: Article

References (44)

1. D. Finley Recognition and processing of ubiquitin-protein conjugates by the proteasome Annu. Rev. Biochem. 78 2009 477 513
2. M. Rechsteiner, and C.P. Hill Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors Trends Cell Biol. 15 2005 27 33
3. M.J. Lee, B.H. Lee, J. Hanna, R.W. King, and D. Finley Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes Mol. Cell. Proteomics 10 2011 R110.003871
4. N.P. Dantuma, and T. Hoppe Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin Trends Cell Biol. 22 2012 483 491
5. Y. Ye Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase J. Struct. Biol. 156 2006 29 40
6. S. Bar-Nun The role of p97/Cdc48p in endoplasmic reticulum-associated degradation: from the immune system to yeast Curr. Top. Microbiol. Immunol. 300 2005 95 125
7. A.L. Goldberg Development of proteasome inhibitors as research tools and cancer drugs J. Cell Biol. 199 2012 583 588
8. J.P. Laubach, C.S. Mitsiades, A.M. Roccaro, I.M. Ghobrial, K.C. Anderson, and P.G. Richardson Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia Leuk. Lymphoma 50 2009 694 702
9. S.K. Radhakrishnan, C.S. Lee, P. Young, A. Beskow, J.Y. Chan, and R.J. Deshaies Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells Mol. Cell 38 2010 17 28
10. J. Steffen, M. Seeger, A. Koch, and E. Krüger Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop Mol. Cell 40 2010 147 158
11. S. Meiners, D. Heyken, A. Weller, A. Ludwig, K. Stangl, P.M. Kloetzel, and E. Krüger Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes J. Biol. Chem. 278 2003 21517 21525
12. A. Ciechanover, and P. Brundin The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg Neuron 40 2003 427 446
13. M. Biswas, D. Phan, M. Watanabe, and J.Y. Chan The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis J. Biol. Chem. 286 2011 39282 39289
14. Y. Tsuchiya, T. Morita, M. Kim, S. Iemura, T. Natsume, M. Yamamoto, and A. Kobayashi Dual regulation of the transcriptional activity of Nrf1 by β-TrCP- and Hrd1-dependent degradation mechanisms Mol. Cell. Biol. 31 2011 4500 4512
15. D. Stewart, E. Killeen, R. Naquin, S. Alam, and J. Alam Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium J. Biol. Chem. 278 2003 2396 2402
16. H.C. Besche, A. Peth, and A.L. Goldberg Getting to first base in proteasome assembly Cell 138 2009 25 28
17. B. Fricke, S. Heink, J. Steffen, P.M. Kloetzel, and E. Krüger The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum EMBO Rep. 8 2007 1170 1175
18. D. Vilchez, I. Morantte, Z. Liu, P.M. Douglas, C. Merkwirth, A.P. Rodrigues, G. Manning, and A. Dillin RPN-6 determines C. elegans longevity under proteotoxic stress conditions Nature 489 2012 263 268
19. A. Tonoki, E. Kuranaga, T. Tomioka, J. Hamazaki, S. Murata, K. Tanaka, and M. Miura Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process Mol. Cell. Biol. 29 2009 1095 1106
20. C. Hetz The unfolded protein response: controlling cell fate decisions under ER stress and beyond Nat. Rev. Mol. Cell Biol. 13 2012 89 102
21. K. Tanaka, and M. Kasahara The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28 Immunol. Rev. 163 1998 161 176
22. P. Cascio, C. Hilton, A.F. Kisselev, K.L. Rock, and A.L. Goldberg 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide EMBO J. 20 2001 2357 2366
23. A. Peth, N. Kukushkin, M. Bossé, and A.L. Goldberg Ubiquitinated proteins activate the proteasomal ATPases by binding to Usp14 or Uch37 homologs J. Biol. Chem. 288 2013 7781 7790
24. J. Hanna, A. Meides, D.P. Zhang, and D. Finley A ubiquitin stress response induces altered proteasome composition Cell 129 2007 747 759
25. A.F. Kisselev, A. Callard, and A.L. Goldberg Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate J. Biol. Chem. 281 2006 8582 8590
26. J. Adams, M. Behnke, S. Chen, A.A. Cruickshank, L.R. Dick, L. Grenier, J.M. Klunder, Y.T. Ma, L. Plamondon, and R.L. Stein Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids Bioorg. Med. Chem. Lett. 8 1998 333 338
27. L. Meng, R. Mohan, B.H. Kwok, M. Elofsson, N. Sin, and C.M. Crews Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity Proc. Natl. Acad. Sci. USA 96 1999 10403 10408
28. A.F. Kisselev, and A.L. Goldberg Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates Methods Enzymol. 398 2005 364 378
29. Y. Zhang, and J.D. Hayes Identification of topological determinants in the N-terminal domain of transcription factor Nrf1 that control its orientation in the endoplasmic reticulum membrane Biochem. J. 430 2010 497 510
30. Y. Zhang, J.M. Lucocq, M. Yamamoto, and J.D. Hayes The NHB1 (N-terminal homology box 1) sequence in transcription factor Nrf1 is required to anchor it to the endoplasmic reticulum and also to enable its asparagine-glycosylation Biochem. J. 408 2007 161 172
31. S.K. Radhakrishnan, W. den Besten, and R.J. Deshaies p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition eLife 3 2014 e01856 10.7554/eLife.01856
32. J.J. Chen, C.A. Tsu, J.M. Gavin, M.A. Milhollen, F.J. Bruzzese, W.D. Mallender, M.D. Sintchak, N.J. Bump, X. Yang, and J. Ma et al. Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues J. Biol. Chem. 286 2011 40867 40877
33. R.K. Anchoori, B. Karanam, S. Peng, J.W. Wang, R. Jiang, T. Tanno, R.Z. Orlowski, W. Matsui, M. Zhao, and M.A. Rudek et al. A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer Cancer Cell 24 2013 791 805
34. V.J. Palombella, O.J. Rando, A.L. Goldberg, and T. Maniatis The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B Cell 78 1994 773 785
35. E.K. Schrader, K.G. Harstad, R.A. Holmgren, and A. Matouschek A three-part signal governs differential processing of Gli1 and Gli3 proteins by the proteasome J. Biol. Chem. 286 2011 39051 39058
36. M. Rape, T. Hoppe, I. Gorr, M. Kalocay, H. Richly, and S. Jentsch Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone Cell 107 2001 667 677
37. M. Kothe, Y. Ye, J.S. Wagner, H.E. De Luca, E. Kern, T.A. Rapoport, and W.I. Lencer Role of p97 AAA-ATPase in the retrotranslocation of the cholera toxin A1 chain, a non-ubiquitinated substrate J. Biol. Chem. 280 2005 28127 28132
38. P. Magnaghi, R. D'Alessio, B. Valsasina, N. Avanzi, S. Rizzi, D. Asa, F. Gasparri, L. Cozzi, U. Cucchi, and C. Orrenius et al. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death Nat. Chem. Biol. 9 2013 548 556
39. M.X. Qian, Y. Pang, C.H. Liu, K. Haratake, B.Y. Du, D.Y. Ji, G.F. Wang, Q.Q. Zhu, W. Song, and Y. Yu et al. Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis Cell 153 2013 1012 1024
40. D. Vilchez, L. Boyer, I. Morantte, M. Lutz, C. Merkwirth, D. Joyce, B. Spencer, L. Page, E. Masliah, and W.T. Berggren et al. Increased proteasome activity in human embryonic stem cells is regulated by PSMD11 Nature 489 2012 304 308
41. K.T. Bush, A.L. Goldberg, and S.K. Nigam Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance J. Biol. Chem. 272 1997 9086 9092
42. D. Berko, S. Tabachnick-Cherny, D. Shental-Bechor, P. Cascio, S. Mioletti, Y. Levy, A. Admon, T. Ziv, B. Tirosh, A.L. Goldberg, and A. Navon The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini Mol. Cell 48 2012 601 611
43. S. Elsasser, M. Schmidt, and D. Finley Characterization of the proteasome using native gel electrophoresis Methods Enzymol. 398 2005 353 363
44. J. Zhao, J.J. Brault, A. Schild, P. Cao, M. Sandri, S. Schiaffino, S.H. Lecker, and A.L. Goldberg FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells Cell Metab. 6 2007 472 483